Molecules
The six molecules in European trials: what they are, who holds them, and where each one stands.
PsilocybinCOMP3605 assets8 European trial records0 deals
LysergideLSD, DT1201 asset2 European trial records0 deals
MDMA3,4-methylenedioxymethamphetamine1 asset1 European trial record0 deals
Mebufotenin5-MeO-DMT, BPL-003, GH0012 assets6 European trial records1 deal
HLP003deuterated psilocin analogue1 asset2 European trial records0 deals- BrenipatideLY35370311 asset15 European trial records0 deals
How a drug reaches a patient in Europe
Where each molecule stands today, by the European record only.
- Preclinical
- Phase 1
- Phase 2
- BPL-003Beckley Psytech / AtaiBeckley
- GH001GH Research
- psilocybin (investigator-led)Region Skane
- psilocybin (investigator-led; PEX010 capsules, 25 mg and 5 mg)ARQ Centrum'45
- psilocybin (investigator-led; PEX010)Slagelse Hospital
- psilocybin with trazodone (investigator-led; PEX010 25 mg and Trittico)University of Chieti-Pescara
- MDMA hydrochloride (investigator-led)Amsterdam UMC
- Phase 3
- Marketing application
- Approved
- Reimbursed